Melanocortin receptor agonist (MC3R/MC4R) that acts centrally in the hypothalamus to stimulate sexual arousal independent of vascular mechanisms.
For athletes, the primary value of PT-141 (Bremelanotide) lies in its ability to libido enhancement and sexual arousal in both men and women.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Nausea most common side effect. Transient blood pressure increase. Not for use in cardiovascular disease.
Always verify current WADA status with your sport's governing body before use in competition.
https://pubmed.ncbi.nlm.nih.gov/15316239/
https://pubmed.ncbi.nlm.nih.gov/30951232/
Start a PT-141 (Bremelanotide) Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified PT-141 (Bremelanotide) and comprehensive biomarker monitoring.
Get ProtocolCompare & Stack
Start Your Performance Protocol for PT-141 (Bremelanotide)
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised